SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-031764
Filing Date
2015-05-15
Accepted
2015-05-15 17:25:43
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v409967_10q.htm 10-Q 453565
2 EXHIBIT 31.1 v409967_ex31-1.htm EX-31.1 9267
3 EXHIBIT 32.1 v409967_ex32-1.htm EX-32.1 5261
  Complete submission text file 0001144204-15-031764.txt   7730618

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT vgen-20150331.xml EX-101.INS 1339527
5 XBRL TAXONOMY EXTENSION SCHEMA vgen-20150331.xsd EX-101.SCH 55479
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vgen-20150331_cal.xml EX-101.CAL 40646
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vgen-20150331_def.xml EX-101.DEF 358536
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vgen-20150331_lab.xml EX-101.LAB 387116
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vgen-20150331_pre.xml EX-101.PRE 418784
Mailing Address 949 FELL STREET BALTIMORE MD 21231
Business Address 949 FELL STREET BALTIMORE MD 21231 410-387-4000
VACCINOGEN INC (Filer) CIK: 0001453001 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 10-Q | Act: 34 | File No.: 000-54997 | Film No.: 15871060
SIC: 2834 Pharmaceutical Preparations